| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/08/2009 | EP2044956A1 Hematopoietic stem cell proliferation promoter |
| 04/08/2009 | EP2044946A1 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 04/08/2009 | EP2044050A1 New pyridine analogues |
| 04/08/2009 | EP2044028A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) |
| 04/08/2009 | EP2044024A1 New pyridine analogues |
| 04/08/2009 | EP2043632A2 New indications for direct thrombin inhibitors |
| 04/08/2009 | EP2043631A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/08/2009 | EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | CN101402661A Uses of iridoid glycoside compounds in preparing hemostatic and pain easing medicament |
| 04/08/2009 | CN101402643A Industrial production method for prasugrel |
| 04/08/2009 | CN101402642A Novel environment friendly preparation method for prasugrel |
| 04/08/2009 | CN101402641A Oxime derivatives containing thienopyridine, preparation method and application thereof |
| 04/08/2009 | CN101402565A Halogenated 2-(a-hydroxyl pentyl) benzoate, production method and uses thereof |
| 04/08/2009 | CN101401932A Injection for treating thrombus |
| 04/08/2009 | CN101401924A Astringency and hemostasis medicament formulation |
| 04/08/2009 | CN101401923A Oral medicine for headache and general edema in pregnancy period |
| 04/08/2009 | CN101401905A Chinese medicinal composition for treating aplastic anemia |
| 04/08/2009 | CN101401901A Compound formulation for medicament for dispelling wind and treating detumescence |
| 04/08/2009 | CN101401891A Traditional Chinese medicine decoction for treating aplastic anemia |
| 04/08/2009 | CN101401856A Proprietary Chinese medicine for treating hemorrhage of digestive tract and preparation method thereof |
| 04/08/2009 | CN101401831A Xuesaitong extract and injection thereof |
| 04/08/2009 | CN101401819A Donkey-hide gelatin effervescent particle and preparation method thereof |
| 04/08/2009 | CN100475777C Amide type carboxamide derivative |
| 04/08/2009 | CN100475248C A medicine for treating metrorrhagia and preparation process thereof |
| 04/08/2009 | CN100475231C Black soybean polysaccharides |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 04/07/2009 | US7514436 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders; [4-(6-Phenethyloxy-pyridazin-3-yl)piperazin-1-yl]-(2-trifluoromethyl-phenyl)-methanone; stearoyl-CoA desaturase modulators |
| 04/07/2009 | US7514095 Three-dimensional chitosan matrix or drug release; tissue engineering ; water in oil emulsion containing active materials; extrusion; coagulation |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/07/2009 | CA2205914C Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009041734A1 Agonistic antibody against human thrombopoietin receptor |
| 04/02/2009 | WO2009041714A1 External preparation for free radical diseases |
| 04/02/2009 | WO2009041072A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 04/02/2009 | WO2009040314A2 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 04/02/2009 | WO2009039704A1 A method for producing human kallikrein 1 |
| 04/02/2009 | WO2009039584A1 Diagnosis and treatment of diseased and damaged tissue |
| 04/02/2009 | WO2009019458A3 Erythropoietin fusion proteins |
| 04/02/2009 | WO2008113030A3 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| 04/02/2009 | WO2006044657A3 Phosphate binder with reduced pill burden |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088384 Therapeutic Fibrin-Derived Peptides And Uses Thereof |
| 04/02/2009 | US20090088371 Combination therapy with syk kinase inhibitor |
| 04/02/2009 | US20090088370 Method for Improved Isolation of Recombinantly Produced Proteins |
| 04/02/2009 | DE102007045476A1 Neue heteroarylsubstituierte Acetonderivate, geeignet zur Hemmung der Phospholipase A2 New heteroaryl acetone derivatives useful for inhibiting phospholipase A2 |
| 04/02/2009 | CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same |
| 04/01/2009 | EP2042591A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 04/01/2009 | EP2042494A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2041115A1 New pyridine analogues |
| 04/01/2009 | EP2041112A1 New pyridine analogues |
| 04/01/2009 | EP2041111A1 New pyridine analogues |
| 04/01/2009 | EP2040729A2 Attenuation of reperfusion injury |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP0888386B2 Stable, virus-safe factor VIII-complex concentrate |
| 04/01/2009 | CN101400671A Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 04/01/2009 | CN101400655A Quinolone derivative or pharmaceutically acceptable salt thereof |
| 04/01/2009 | CN101396561A Use of composition containing ACEI in preparing medicine for treating hyperhomocysteinemia injury and related diseases thereof |
| 04/01/2009 | CN101396525A Traditional Chinese medicine preparation for treating cerebrovascular disease |
| 04/01/2009 | CN101396492A Quality control method for toxin ingredient, yunaconitine in Yuannan Hongyao capsule |
| 04/01/2009 | CN101396356A New use of bilobalide |
| 04/01/2009 | CN101396350A Clopidogrel hydrogen sulfate dispersible tablets and preparation method thereof |
| 04/01/2009 | CN100473415C Health-care product for treating cardiovascular and cerebralvascular disease |
| 04/01/2009 | CN100473401C Chinese medicine preparation for preventing and treating cerebral thrombus and sequel thereof |
| 04/01/2009 | CN100473390C Method for preparing pharmaceutics of a single drug of japanese ginseng and general saponin thereof |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511053 Spiroazacyclic compounds as monoamine receptor modulators |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510728 Solid preparations |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/31/2009 | CA2192467C Calcium binding recombinant antibody against protein c |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009007457A3 Compounds and methods for modulating rho gtpases |
| 03/26/2009 | WO2008094617A3 Crystalline forms of deferasirox |
| 03/26/2009 | WO2008042422A3 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 03/26/2009 | US20090082444 Compositions for the Treatment of Blood Disorders |
| 03/26/2009 | US20090082380 Deuterium-enriched rosuvastatin |
| 03/26/2009 | US20090082357 Prolyl Hydroxylase Inhibitors |
| 03/26/2009 | US20090082302 Modulation of eif4e-bp2 expression |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081216 Treatment of pathologies which escape the immune response, using optimized antibodies |
| 03/26/2009 | US20090081188 Complex of factorix and polyoxyethylene glycol; stimulant blood coagulation; blood disorders |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039357A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |